Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,653,739
+$127,255 QoQ
Shares Held
16,933
+2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#373
of 1,603 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 16%
Shared 0%
None 84%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BTC Capital Management, Inc. holds $72,536,732 across 7 Drug Manufacturers - General names. NVS ranks #5 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
75,841 | $19,084,627 | |
| 2 | JNJ |
Johnson & Johnson
|
71,998 | $18,285,330 | |
| 3 | LLY |
ELI LILLY & Co
|
13,431 | $16,109,544 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
113,516 | $14,341,610 | |
| 5 | NVS |
Novartis AG
This page
|
16,933 | $2,653,739 | |
| 6 | SNY |
Sanofi
|
43,138 | $1,840,266 | |
| 7 | AMGN |
Amgen Inc
|
612 | $221,616 |
All Filings in NVS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,653,739 | 16,933 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,526,484 | 16,540 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $2,395,903 | 17,378 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $2,215,858 | 17,279 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,906,027 | 15,751 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $1,714,896 | 15,383 | Shares | Defined | 2025-04-08 | |
| 2024-12-31 | $1,450,890 | 14,910 | Shares | Defined | 2025-01-23 | |
| 2024-09-30 | $1,529,994 | 13,302 | Shares | Defined | 2024-10-21 | |
| 2024-06-30 | $1,328,726 | 12,481 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,247,912 | 12,901 | Shares | Sole | 2024-04-11 | |
| 2023-09-30 | $1,179,028 | 11,575 | Shares | Defined | 2023-10-17 | |
| 2023-06-30 | $1,121,412 | 11,113 | Shares | Defined | 2023-07-11 | |
| 2023-03-31 | $1,035,552 | 11,256 | Shares | Defined | 2023-04-07 | |
| 2022-12-31 | $1,105,875 | 12,190 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $879,130 | 11,566 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $902,188 | 10,673 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $1,820,636 | 20,748 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $934,441 | 10,683 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $827,203 | 10,115 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $904,187 | 9,910 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $1,003,705 | 11,742 | Shares | Defined | 2021-05-04 | |
| 2020-12-31 | $1,044,772 | 11,064 | Shares | Defined | 2021-01-28 | |
| 2020-09-30 | $858,033 | 9,867 | Shares | Defined | 2020-10-14 | |
| 2020-06-30 | $550,329 | 6,301 | Shares | Defined | 2020-08-04 | |
| No filing history on record for this holder in this stock. | ||||||